Search Results 251-260 of 541 for ✈010인증 대량소량인증 ㅌㄹ@KORID010 010 성인인증 가입인증✈

  1. A Study Using Targeted Inhibitors to Treat Specific Tumor Mutations in Patients with Meningiomas - Mayo Clinic

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

  2. A Study of Benralizumab in Patients With Eosinophilic Esophagitis - Mayo Clinic

    The purpose of this study is to compare the effect of benralizumab 30 mg every 4 weeks (Q4W) with placebo on histologic signs and gastrointestinal symptoms in ...

  3. PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer - Mayo Clinic

    About this study. A Phase II study to investigate the potential utility of PD 0332991 in the treatment of early stage ER+ Human epidermal growth factor ...

  4. A Study to Determine the Effectiveness and Safety of Luspatercept in Patients with Myelodysplastic/ Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis - Mayo Clinic

    Luspatercept is approved by the U.S. Food and Drug Administration (FDA) for patients with anemia who require RBC blood transfusions with very low- to ...

  5. Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery - Mayo Clinic

    Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving pembrolizumab, combination chemotherapy, and radiation therapy before ...

  6. And/or HPV-11- Associated Recurrent Respiratory Papillomatosis for Patients who Previously Received INO-3107 - Mayo Clinic

    The purpose of this study is to evaluate the effiectiveness and tolerability of INO-3107 in subjects with HPV6 and/or HPV-11- associated RRP, who have ...

  7. Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    About this study. The purpose of this study is to establish the Recommended Phase 2 Dose (RP2D), safety, pharmacokinetics (PK), pharmacodynamics (PD), ...

  8. IL-33 Production by Nasal Epithelial Cells - Mayo Clinic

    About this study. This research study is being done for people who have asthma and chronic rhinosinusitis, hay fever, or you do not have any sinus disease, ...

  9. UBX1325 for Treatment of Neovascular ARMD - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

    Monoclonal antibodies, such as anetumab ravtansine and atezolizumab, may interfere with the ability of tumor cells to grow and spread. Participation eligibility.